463 related articles for article (PubMed ID: 19273702)
21. [Infectious and non-infectious complications of tunneled central catheters in hematologic patients].
Albo López C; López Rodríguez D; Constenla Camba MI; Jimenéz Blanco A; Araujo LF; García-Medina J
Sangre (Barc); 1999 Jun; 44(3):176-81. PubMed ID: 10481577
[TBL] [Abstract][Full Text] [Related]
22. A vancomycin-heparin lock solution for prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: a prospective, randomized trial.
Garland JS; Alex CP; Henrickson KJ; McAuliffe TL; Maki DG
Pediatrics; 2005 Aug; 116(2):e198-205. PubMed ID: 15995005
[TBL] [Abstract][Full Text] [Related]
23. Heparin versus 0.9% sodium chloride intermittent flushing for the prevention of occlusion in long term central venous catheters in infants and children.
Bradford NK; Edwards RM; Chan RJ
Cochrane Database Syst Rev; 2015 Nov; (11):CD010996. PubMed ID: 26590504
[TBL] [Abstract][Full Text] [Related]
24. Accuracy of bacterial DNA testing for central venous catheter-associated bloodstream infection in children with cancer.
Millar M; Zhou W; Skinner R; Pizer B; Hennessy E; Wilks M; Gilbert RE
Health Technol Assess; 2011 Feb; 15(7):1-114. PubMed ID: 21294989
[TBL] [Abstract][Full Text] [Related]
25. Prevention of indwelling central venous catheter sepsis.
Daghistani D; Horn M; Rodriguez Z; Schoenike S; Toledano S
Med Pediatr Oncol; 1996 Jun; 26(6):405-8. PubMed ID: 8614377
[TBL] [Abstract][Full Text] [Related]
26. Catheter-related deep venous thrombosis and other catheter complications in children with cancer.
Journeycake JM; Buchanan GR
J Clin Oncol; 2006 Oct; 24(28):4575-80. PubMed ID: 17008698
[TBL] [Abstract][Full Text] [Related]
27. Prophylactic antibiotics for preventing Gram positive infections associated with long-term central venous catheters in oncology patients.
van de Wetering MD; van Woensel JB; Lawrie TA
Cochrane Database Syst Rev; 2013 Nov; 2013(11):CD003295. PubMed ID: 24277633
[TBL] [Abstract][Full Text] [Related]
28. Incidence of thrombotic complications in patients with haematological malignancies with central venous catheters: a prospective multicentre study.
Cortelezzi A; Moia M; Falanga A; Pogliani EM; Agnelli G; Bonizzoni E; Gussoni G; Barbui T; Mannucci PM;
Br J Haematol; 2005 Jun; 129(6):811-7. PubMed ID: 15953009
[TBL] [Abstract][Full Text] [Related]
29. [Complications associated with central venous catheters in patient with hematologic neoplasms or hematopoietic transplants].
Gutiérrez AM; Solano C; Gimeno C; García-Conde J
Sangre (Barc); 1999 Jun; 44(3):171-5. PubMed ID: 10481576
[TBL] [Abstract][Full Text] [Related]
30. Trisodium citrate 4%--an alternative to heparin capping of haemodialysis catheters.
Lok CE; Appleton D; Bhola C; Khoo B; Richardson RM
Nephrol Dial Transplant; 2007 Feb; 22(2):477-83. PubMed ID: 17018541
[TBL] [Abstract][Full Text] [Related]
31. Concentration of heparin-locking solution and risk of central venous hemodialysis catheter malfunction.
Thomas CM; Zhang J; Lim TH; Scott-Douglas N; Hons RB; Hemmelgarn BR;
ASAIO J; 2007; 53(4):485-8. PubMed ID: 17667236
[TBL] [Abstract][Full Text] [Related]
32. Diagnosis of catheter-related bloodstream infection in a total parenteral nutrition population: inclusion of sepsis defervescence after removal of culture-positive central venous catheter.
Walshe CM; Boner KS; Bourke J; Hone R; Phelan D
J Hosp Infect; 2010 Oct; 76(2):119-23. PubMed ID: 20554348
[TBL] [Abstract][Full Text] [Related]
33. Results of a long-term, prospective study on complications of central venous catheter in pediatric patients with hematologic-oncologic diseases.
Garonzi C; Zeni F; Tridello G; Giacomazzi A; Castagna A; Esposto MP; Caddeo G; Pezzella V; Zaccaron A; Bonetti E; Vitale V; Chinello M; Balter R; Guardini B; Pedrazzoli E; Cesaro S
Pediatr Blood Cancer; 2024 Jul; 71(7):e30990. PubMed ID: 38605511
[TBL] [Abstract][Full Text] [Related]
34. Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer.
Couban S; Goodyear M; Burnell M; Dolan S; Wasi P; Barnes D; Macleod D; Burton E; Andreou P; Anderson DR
J Clin Oncol; 2005 Jun; 23(18):4063-9. PubMed ID: 15767639
[TBL] [Abstract][Full Text] [Related]
35. Post-thrombotic syndrome after central venous catheter removal in childhood cancer survivors is associated with a history of obstruction.
Revel-Vilk S; Menahem M; Stoffer C; Weintraub M
Pediatr Blood Cancer; 2010 Jul; 55(1):153-6. PubMed ID: 20232430
[TBL] [Abstract][Full Text] [Related]
36. [Prevention of catheter-related infection: usefulness and cost-effectiveness of antiseptic catheters in children].
Lenz AM; Vassallo JC; Moreno GE; Althabe M; Gómez S; Magliola R; Casimir L; Bologna R; Barretta J; Ruffa P
Arch Argent Pediatr; 2010 Jun; 108(3):209-15. PubMed ID: 20544135
[TBL] [Abstract][Full Text] [Related]
37. Skin disinfection with octenidine dihydrochloride for central venous catheter site care: a double-blind, randomized, controlled trial.
Dettenkofer M; Wilson C; Gratwohl A; Schmoor C; Bertz H; Frei R; Heim D; Luft D; Schulz S; Widmer AF
Clin Microbiol Infect; 2010 Jun; 16(6):600-6. PubMed ID: 19686276
[TBL] [Abstract][Full Text] [Related]
38. [Venous thromboembolism associated with long-term use of central venous catheters in cancer patients].
Debourdeau P; Chahmi DK; Zammit C; Farge-Bancel D
Pathol Biol (Paris); 2008 Jun; 56(4):211-9. PubMed ID: 18395994
[TBL] [Abstract][Full Text] [Related]
39. A randomized trial comparing gentamicin/citrate and heparin locks for central venous catheters in maintenance hemodialysis patients.
Moran J; Sun S; Khababa I; Pedan A; Doss S; Schiller B
Am J Kidney Dis; 2012 Jan; 59(1):102-7. PubMed ID: 22088576
[TBL] [Abstract][Full Text] [Related]
40. A randomized controlled trial for maintaining peripheral intravenous lock in children.
Mok E; Kwong TK; Chan MF
Int J Nurs Pract; 2007 Feb; 13(1):33-45. PubMed ID: 17244243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
